# Fine-tuning ERK activity enables proliferation-differentiation balance during lineage specification of human embryonic stem cells

**Authors:** Chenyang Ma, Weikang Meng, Jinghan Huang, Wanling Zheng, Xiao Xu, Tao Cheng, Zhengyi Li, Yang Liu, Hao Shen, Feng He, Alessandro Esposito, Pengfei Xu, Ashok Venkitaraman, Jun Ma, Heng Xu, Hongqing Liang, Ines Alvarez-Garcia, Ines Alvarez-Garcia, Ines Alvarez-Garcia, Ines Alvarez-Garcia

PMC · DOI: 10.1371/journal.pbio.3003711 · PLOS Biology · 2026-03-17

## TL;DR

The study shows how ERK signaling balances stem cell differentiation and division during early human development.

## Contribution

The research reveals how ERK activity fine-tunes differentiation and proliferation in mesendoderm lineage specification.

## Key findings

- Distinct morphogen combinations generate varying ERK activity levels linked to heterogeneous mesendoderm fate choices.
- Titrated ERK activity enables quantitative control of mesendoderm differentiation without major impact on cell cycle progression.
- ERK modulates differentiation and proliferation via differential sensitivities of lineage and cell cycle genes.

## Abstract

ERK is a key signaling mediator controlling both proliferation and lineage specification during embryo development. How ERK choreographs differentiation and proliferation to achieve balanced developmental outcomes in lineages with variable ERK activities remains unclear. To investigate this, we established multiplex quantitative live-cell imaging to track human pluripotent stem cell differentiation into mesendoderm (ME), a lineage specified by gastrulation morphogens and dependent on high ERK activity. We found that distinct morphogen combinations generate varying ERK activity levels, which correlate with heterogeneous ME fate choices despite relatively uniform cell cycle dynamics. To dissect how heterogenous ERK levels directly modulate and coordinate ME differentiation and proliferation, we engineered a synthetic spectrum of titrated ERK activities. Our results showed that ERK fine-tunes ME differentiation potential and cell division speed under nonoverlapping activity ranges, enabling quantitative control of ME fate specification without major effect on cell cycle progression. Mechanistically, this uncoupling stems from differential transcriptional and translational sensitivities of ME-specifying genes versus cell cycle genes to ERK input. Together, our findings reveal how a single signaling pathway quantitatively balances differentiation and proliferation during lineage commitment and embryogenesis.

ERK is a signalling mediator that regulates both proliferation and lineage specification during embryo development, however the mechanisms to achieve this remain unclear. This study shows that ERK levels modulate human pluripotent stem cell differentiation into mesendoderm by fine-tuning its differentiation potential and cell division speed.

## Linked entities

- **Genes:** EPHB2 (EPH receptor B2) [NCBI Gene 2048]
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** SOX17 (SRY-box transcription factor 17) [NCBI Gene 64321] {aka PPH7, VUR3}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, EGR1 (early growth response 1) [NCBI Gene 1958] {aka AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268}, MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609] {aka JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, PAX6 (paired box 6) [NCBI Gene 5080] {aka AN, AN1, AN2, ASGD5, D11S812E, FVH1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, ATP7A (ATPase copper transporting alpha) [NCBI Gene 538] {aka DSMAX, HMNX, MK, MNK, SMAX3}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, NODAL (nodal growth differentiation factor) [NCBI Gene 4838] {aka HTX5}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1) [NCBI Gene 1978] {aka 4E-BP1, 4EBP1, BP-1, PHAS-I}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, H2BC21 (H2B clustered histone 21) [NCBI Gene 8349] {aka GL105, H2B, H2B-GL105, H2B.1, H2BE, H2BFQ}, EIF4E (eukaryotic translation initiation factor 4E) [NCBI Gene 1977] {aka AUTS19, CBP, EIF4E1, EIF4EL1, EIF4F, eIF-4E}, KCNH8 (potassium voltage-gated channel subfamily H member 8) [NCBI Gene 131096] {aka ELK, ELK1, Kv12.1, elk3, hElk-1}, EIF4A2 (eukaryotic translation initiation factor 4A2) [NCBI Gene 1974] {aka BM-010, DDX2B, EIF4A, EIF4F, NEDHSS, eIF-4A-II}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, EOMES (eomesodermin) [NCBI Gene 8320] {aka TBR2}, POU5F1 (POU class 5 homeobox 1) [NCBI Gene 5460] {aka OCT3, OCT4, OCT4Borf1, OTF-3, OTF3, OTF4}, ELK1 (ETS transcription factor ELK1) [NCBI Gene 2002], ME1 (malic enzyme 1) [NCBI Gene 4199] {aka HUMNDME, MES}, SNAI1 (snail family transcriptional repressor 1) [NCBI Gene 6615] {aka SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1}, BMP4 (bone morphogenetic protein 4) [NCBI Gene 652] {aka BMP2B, BMP2B1, MCOPS6, OFC11, ZYME}, CDK2 (cyclin dependent kinase 2) [NCBI Gene 1017] {aka CDKN2, p33(CDK2)}, CCNE1 (cyclin E1) [NCBI Gene 898] {aka CCNE, pCCNE1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, ME2 (malic enzyme 2) [NCBI Gene 4200] {aka ODS1}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, CCNA2 (cyclin A2) [NCBI Gene 890] {aka CCN1, CCNA}, GATA6 (GATA binding protein 6) [NCBI Gene 2627], MIXL1 (Mix paired-like homeobox) [NCBI Gene 83881] {aka MILD1, MIX, MIXL}
- **Diseases:** congenital defects (MESH:D000013), tumorigenesis (MESH:D063646)
- **Chemicals:** CHX (MESH:D003513), pipecolic acid (MESH:C031345), 2-Mercaptoethanol (MESH:D008623), formaldehyde (MESH:D005557), PBS (MESH:D007854), Polyethylene Glycol (MESH:D011092), PI (MESH:D010716), CO2 (MESH:D002245), sucrose (MESH:D013395), HCl (MESH:D006851), NaCl (MESH:D012965), puromycin (MESH:D011691), glucose (MESH:D005947), N2 (MESH:D009584), glycine (MESH:D005998), DMEM (-), TRITC (MESH:C009434), Thiazovivin (MESH:C545214), GABA (MESH:D005680), PVDF (MESH:C024865), HPG (MESH:C551041), L-glutamine (MESH:D005973), Ulix (MESH:D019832), methionine (MESH:D008715), Triton X-100 (MESH:D017830), FBS (MESH:C523711), ethanol (MESH:D000431), Polyethylenimine (MESH:D011094), Ulixertinib (MESH:C000618314), FITC (MESH:D016650), SDS (MESH:D012967), DAPI (MESH:C007293), PFA (MESH:C003043), lipid (MESH:D008055), LiCl (MESH:D018021), CY5 (MESH:C085321), Alexa Fluor 555 (MESH:C000608607), EDTA (MESH:D004492), PD0325901 (MESH:C506614)
- **Species:** Lentivirus (genus) [taxon 11646], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** H1 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_HA53), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), hESC — Gallus gallus (Chicken), Somatic stem cell (CVCL_JE75)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13012617/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13012617/full.md

## References

82 references — full list in the complete paper: https://tomesphere.com/paper/PMC13012617/full.md

---
Source: https://tomesphere.com/paper/PMC13012617